本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Enanta Pharmaceuticals Inc.

7.81
+0.16002.09%
成交量:3.19万
成交额:24.75万
市值:1.67亿
市盈率:-1.72
高:7.90
开:7.60
低:7.56
收:7.65
数据加载中...
2022/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/08

重要事件披露

8-K - Current report
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/23

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/23

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/23

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/23

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

重要事件披露

8-K - Current report
2021/08/23

重要事件披露

8-K - Current report
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]